Oxford Cannabinoid Technologies Holdings (LSE:OCTP) LT-Debt-to-Total-Asset : 0.00 (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Oxford Cannabinoid Technologies Holdings's long-term debt to total assests ratio for the quarter that ended in Oct. 2023 was 0.00.

Oxford Cannabinoid Technologies Holdings's long-term debt to total assets ratio stayed the same from Oct. 2022 (0.00) to Oct. 2023 (0.00).

Oxford Cannabinoid Technologies Holdings LT-Debt-to-Total-Asset Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings LT-Debt-to-Total-Asset Chart

Oxford Cannabinoid Technologies Holdings Annual Data

Trend

May18

May19

May20

May21

Apr23

LT-Debt-to-Total-Asset

0.04

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
	May19	Nov19	May20	Nov20	May21	Nov21	Oct22	Apr23	Oct23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial				-	-	-	-	-

Oxford Cannabinoid Technologies Holdings LT-Debt-to-Total-Asset Calculation

Oxford Cannabinoid Technologies Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Apr. 2023 is calculated as

LT Debt to Total Assets (A: Apr. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Apr. 2023 )	/	Total Assets (A: Apr. 2023 )
	=	0	/	4.496
	=

Oxford Cannabinoid Technologies Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Oct. 2023 is calculated as

LT Debt to Total Assets (Q: Oct. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Oct. 2023 )	/	Total Assets (Q: Oct. 2023 )
	=	0	/	2.79
	=

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Oxford Cannabinoid Technologies Holdings LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

0CB:Germany

Address

267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT

Website

https://www.oxcantech.com

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Headlines

No Headlines